Hyderabad based NATCO Pharma Limited had recommended a payment of Rs. 2 per equity share as an interim dividend for the financial year 2009-10.
The Board of Directors, which met at Hyderabad today, noted that the company has recorded a 11% growth in revenues on a year-on-year on basis (at Rs. 83 Crores in the third quarter of the current fiscal as against Rs. 75 Crores in the last year). The net profit, after tax, on a stand-alone basis has also gone up by 7% on a year-on-year basis (from Rs. 1128 lakhs to Rs. 1209 lakhs) in the third quarter of the current year.
On a consolidated basis, the cumulative earnings up to end of December, 2009 amounted to Rs. 349 Crores (as against Rs. 331 Crores last year), while the cumulative profit after tax stood at Rs. 3368 lakhs (as against Rs. 3271 lakhs last year).
The Board has fixed Friday, the 8th February, 2010 as the record date for the payment of dividend